Haoyue Hu

ORCID: 0000-0003-2706-0321 · 7 papers in corpus
2026
·doi:10.6084/m9.figshare.32870966.v1

Additional file 1: Supplementary figures and tables.

2026
·doi:10.6084/m9.figshare.32870966

Additional file 1: Supplementary figures and tables.

lab-animal 2026
·doi:10.6084/m9.figshare.c.8571011.v1

Abstract Background Pro-EGCG has shown therapeutic promise for endometriosis, yet its immunoregulatory mechanisms remain unclear. Myeloid-derived suppressor cells (MDSCs) are key drivers of disease progression. This study investigates wheth…

lab-animal 2026
Chinese medicine ·doi:10.1186/s13020-026-01451-8

BACKGROUND: Pro-EGCG has shown therapeutic promise for endometriosis, yet its immunoregulatory mechanisms remain unclear. Myeloid-derived suppressor cells (MDSCs) are key drivers of disease progression. This study investigates whether Pro-E…

lab-animal 2026
·doi:10.6084/m9.figshare.c.8571011

Abstract Background Pro-EGCG has shown therapeutic promise for endometriosis, yet its immunoregulatory mechanisms remain unclear. Myeloid-derived suppressor cells (MDSCs) are key drivers of disease progression. This study investigates wheth…

other 2025
American journal of translational research ·doi:10.62347/AOPY5249

OBJECTIVE: Endometriosis increases ovarian cancer (OC) risk through genetic mutations, chronic inflammation, and hormonal dysregulation, yet the underlying molecular pathways remain underexplored. This study aims to identify endometriosis-a…

review 2021
Journal of Cancer ·doi:10.7150/jca.57880

An initial diagnosis of cancer is usually based on symptoms, abnormal physical examination and imaging tests. Ovarian cancer is difficult to be diagnosed timely due to the nonspecific symptoms, thus resulting in the high-risk mortality. Des…